• National cross-disciplinary research ethics and integrity study: methodology and results from Estonia
    with Mari-Liisa Parder, Anu Tammeleht, and Kadri Lees
    Research Ethics. forthcoming.
    While empirical studies of research ethics and integrity are increasingly common, few have aimed at national scope, and even fewer at current results from Central and Eastern Europe. This article introduces the results of the first national research integrity survey in Estonia, which included all research-performing organisations in Estonia, was inclusive of all disciplines and all levels of experience. A web-based survey was developed and carried out in Estonia with a call sent to all accredite…Read more
  •  282
    Supervision, Mentorship and Peer Networks: How Estonian Early Career Researchers Get (or Fail to Get) Support
    with Jaana Eigi, Katrin Velbaum, Endla Lõhkivi, and Kristin Kokkov
    RT. A Journal on Research Policy and Evaluation 6 (1): 01-16. 2018.
    The paper analyses issues related to supervision and support of early career researchers in Estonian academia. We use nine focus groups interviews conducted in 2015 with representatives of social sciences in order to identify early career researchers’ needs with respect to support, frustrations they may experience, and resources they may have for addressing them. Our crucial contribution is the identification of wider support networks of peers and colleagues that may compensate, partially or eve…Read more
  •  10
    Can Theories of Global Justice Be Useful in Humanitarian Response?
    Cambridge Quarterly of Healthcare Ethics 27 (2): 261-270. 2018.
  •  11
  •  39
    This article focuses on healthcare ethics discussions in Estonia. We begin with an overview of the reform policies that the healthcare institutions have undergone since the region regained independence from the Soviet Union in 1991. The principles of distributing healthcare services and questions regarding just what ethical healthcare should look like have received abundant coverage in the national media. An example of this is the exceptionally public case of V—a woman with leukemia whose expens…Read more
  •  87
    The Concepts of Common Good and Public Interest: From Plato to Biobanking
    Cambridge Quarterly of Healthcare Ethics 20 (4): 554-562. 2011.
    The expression “common good” usually conjures up benevolent associations: it is something to be desired, a worthy goal, and it would be a brave person who declared he or she was against the common good. Yet modern times have taught us to be critical and even suspicious of such grand rhetoric, leading us to query what lies behind this ambitious notion, who formulates what it stands for, and how such formulations have been reached
  •  9
    The Human Genome Project and the related research and development activities have raised heated discussions around some very basic ethical and social issues. A much debated concern is that of justice in human genetic research and in possible applications, especially pertaining to questions of just benefit-sharing - who and based on what sort of argumentation has the right to require benefits arising from research and discoveries, and what can even be considered as benefits? In what follows I wil…Read more
  •  29
    Guest Editorial: A Call for Contextualized Bioethics: Health, Biomedical Research, and Security
    Cambridge Quarterly of Healthcare Ethics 20 (4): 511-513. 2011.
    A decade has passed since the mapping of the human genome—an event that paved the way for many new developments in biomedicine and related fields. In ethics, this milestone was accompanied by calls for changes in ruling ethical frameworks
  •  4
    Editorial
    with Henrik Lerner
    Studia Philosophica Estonica 6 (2): 1-5. 2013.
  • Pharmaceuticals
    with Margit Sutrop
    In Ruth Chadwick, Henk ten Have & E. M. Meslin (eds.), SAGE Handbook of Healthcare Ethics, Sage Publications. pp. 427-439. 2011.
    This paper is concerned with analyzing transformations in the development, marketing, prescription, and access issues of pharmaceuticals, paying special attention to a variety of ethical and social aspects. A major focus of the article is on pharmacogenetics – a rapidly developing discipline which in the near future might well have a major effect on both drug development and clinical medicine.